Trending Now
Ginkgo Bioworks (NYSE: DNA) Signs Memorandum Of Understanding To Offer Biosecurity...
Ginkgo Bioworks (NYSE: DNA) has signed a Memorandum of Understanding with the intent to create and implement new biosecurity capabilities in Rwanda.
Ginkgo to collaborate...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
BM Technologies ($BMTX) Acquired by First Carolina Bank in $67 Million...
Digital Banking Platform Finds a New Home
In a move that surprised many market watchers, BM Technologies (NYSE American:BMTX),...
MAKE IT MODERN
LATEST REVIEWS
Athersys Inc.’s (NASDAQ: ATHX) Japanese Partner Releases Positive ONE-BRIDGE Results...
Athersys Inc. (NASDAQ: ATHX) has announced that its Japanese partner HELIOS K.K has announced positive topline data from the ONE-BRIDGE clinical study assessing efficacy...
MAKE IT MODERN
PERFORMANCE TRAINING
As Inflation Spikes, Squeeze Candidates Remain in the Commodity Space (BTU, CEI, CHK, FCX,...
“Team Transitory” at the Fed is coming under increasing pressure. Chair Powell and his core allies seem to be at odds with...
Reason why Inspirato Incorporated (ISPO) has high trading volume today
Inspirato Incorporated (NASDAQ: ISPO), the innovative luxury travel club, has recently garnered significant attention following a stock awareness program. Despite the stock...
XPeng Inc (NYSE:XPEV) could be the dark horse in the EV race
Chinese stocks are gapping higher this morning and unlike U.S tech stocks so far are holding those gains.
The...
AIM ImmunoTech Inc. (NYSEAMERICAN:AIM) Announce Promising Survival Results Of Study Of Ampligen In Advanced...
AIM ImmunoTech Inc (NYSEAMERICAN:AIM) has announced that it has received a statistically significant promising pancreatic cancer survival results from its multi-year Early Access Program...
S&P 500 ready to give back all gains
As we come to the close of a hectic quarter, traders are still trying to put the pieces of the puzzle together...
MAKE IT MODERN
